Dr. Jia Luo 罗嘉
Chief Physician
Department of Hepatobiliary and Intestinal Surgery, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of primary liver cancer, biliary and pancreatic malignancies, colorectal cancer, and other common surgical tumors.
Dr. Luo is Director of the Hepatobiliary and Intestinal Surgery Department and holds a doctorate in surgery from Xiangya School of Medicine, Central South University. A visiting scholar at Mayo Clinic (US), Henri Mondor Hospital, and Montpellier Cancer Center (France), Dr. Luo has led three provincial research projects and published over ten professional papers, including four SCI articles.
Professional roles
- Member, Liver Cancer Group of Hepatobiliary and Pancreatic Professional Committee, Chinese Research Hospital Association
- Member, Biliary Tract Tumor Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Vice Chair, Biliary Tract Tumor Professional Committee, Hunan Anti-Cancer Association
- Standing Committee Member, Second Committee of Liver Cancer Professional Committee, Hunan Anti-Cancer Association
Name order: in Chinese the family name comes first (Luo Jia). Papers usually list the name as Jia Luo or Luo J.
Selected publications
28 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Chin Med J (Engl), 2026 (senior author): Sublethal heat stress-induced HSF4 upregulation via GRSF1 in an m6A-dependent manner in hepatocellular carcinoma. PubMed 42754818
- Cell Death Discov, 2025 (senior author): Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1. PubMed 40301310
- J Inflamm Res, 2025 (senior author): Comment on "Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study" [Response to Letter]. PubMed 40255657
- J Inflamm Res, 2024 (senior author): Peripheral T Lymphocyte Predicts the Prognosis of Gastric Cancer Patients Undergoing Radical Gastrectomy: A Multicenter Retrospective Cohort Study. PubMed 39670156
- Gastric Cancer, 2023 (senior author): Prognostic value of post-operative serum procalcitonin in gastric adenocarcinoma patients undergoing radical gastrectomy: propensity score matching analysis of extended cohort from a prospective bi-center study. PubMed 37578602
- Ann Surg Oncol, 2021 (senior author): ASO Author Reflections: Association Between Perioperative Blood Transfusion, Infections, and Prognosis of Stage II/III Gastric Cancer Patients. PubMed 32901310
- Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2018 (senior author): [Preliminary use of HoloLens glasses in surgery of liver cancer]. PubMed 29886465
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion